Stay updated on KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial

Sign up to get notified when there's something new on the KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The recruitment status was updated to 'No longer looking for participants,' signaling that the study is no longer enrolling. A revision tag was added ('Revision: v3.6.0') and the previous revision tag ('Revision: v3.5.5') was removed, updating the record's revision history.
    Difference
    0.3%
    Check dated 2026-06-13T00:32:08.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    This update adds the latest revision entry (v3.5.5) to the history and removes the prior revision (v3.5.4), reflecting an update to the page's revision log.
    Difference
    0.1%
    Check dated 2026-06-05T22:11:48.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page’s revision history now includes a new entry showing the update from v3.5.3 to v3.5.4. This represents a small interface or backend update to the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-05-15T05:53:48.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s revision/version indicator was updated from v3.5.2 to v3.5.3 in the footer.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:49.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed in the version history.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:38.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Sponsor line updated to Karuna Therapeutics, Inc., a Bristol Myers Squibb company.
    Difference
    0.2%
    Check dated 2026-04-02T15:24:51.000Z thumbnail image

Stay in the know with updates to KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial page.